Literature DB >> 31699300

Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis.

Miguel A Piris1, L Jeffrey Medeiros2, Kung-Chao Chang3.   

Abstract

Hodgkin lymphoma (HL) is composed of two distinct pathological entities, nodular lymphocyte predominant HL and classic HL, the latter with four subtypes. In contrast with most other human lymphomas, in which the neoplastic cells are a major population of the tumour constituents, the neoplastic 'Hodgkin (H) and Reed-Sternberg (RS)' cells usually account for less than 10% of tumour bulk against an inflammatory background. The neoplastic cells of HL are of B-cell lineage (PAX5+) in virtually all cases. HL usually affects young patients with a localised nodal disease and its clinical behaviour is typically indolent. Patients respond well to chemotherapy with cure rates of 80-90% and the recent finding of PD-L1 expression, an immune checkpoint, warrants the use of immunotherapy for some patients with recurrent and/or refractory HL. The enigmatic RS cells of HL are unique in their abundant cytoplasm and characteristic bilobed nuclei with eosinophilic prominent nucleoli, imparting an 'owl-eye' appearance. H cells are mononuclear variants. The viral inclusion-like morphology was a clue on the way to discovering an association between classic HL and Epstein-Barr virus (EBV). However, this association is variable in different geographic regions and in pathological subtypes, and correlates with older age (>60 years) and socioeconomic status, indicating that environmental factors are likely involved in HL pathogenesis. Virus-associated endoplasmic reticulum (ER) stress also may contribute to mechanisms underlying the characteristic morphological features of HRS cells. ER stress has been found to induce aberrant, cytoplasmic cyclin A expression, leading to nuclear hyperdiploidy. Aberrant expression of cyclin A is commonly associated with HRS cell morphology in HL, probably through EBV-latent membrane protein-1 (LMP1) signalling. Shelterin also may play a role in the morphogenesis of multinucleated RS cells. In addition, EBV-positive and -negative HL cases express survival, but not death signals of ER stress at similar levels and EBV-LMP1 transfection increases expression of survival signals in HL cell lines. These data suggest that surviving ER stress may be involved in HL pathogenesis.
Copyright © 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epstein–Barr virus; Hodgkin lymphoma; differential diagnosis; epidemiology; morphology; pathogenesis

Year:  2019        PMID: 31699300     DOI: 10.1016/j.pathol.2019.09.005

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  22 in total

Review 1.  An Update on the Pathology and Molecular Features of Hodgkin Lymphoma.

Authors:  Akira Satou; Taishi Takahara; Shigeo Nakamura
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

Review 2.  Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.

Authors:  Thomas A Tousseyn; Rebecca L King; Falko Fend; Andrew L Feldman; Pierre Brousset; Elaine S Jaffe
Journal:  Virchows Arch       Date:  2022-10-24       Impact factor: 4.535

Review 3.  Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies.

Authors:  Deepak Narayanan Iyer; Omar Faruq; Lun Zhang; Nasrin Rastgoo; Aijun Liu; Hong Chang
Journal:  Biomark Res       Date:  2021-05-06

Review 4.  Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer.

Authors:  Francisco Aguayo; Enrique Boccardo; Alejandro Corvalán; Gloria M Calaf; Rancés Blanco
Journal:  Infect Agent Cancer       Date:  2021-06-30       Impact factor: 2.965

5.  Variable Expression of Notch1 and Pax5 in Classical Hodgkin Lymphoma and Infection with Epstein-Barr in Pediatric Patients.

Authors:  Icela Palma-Lara; Ana Elena Sánchez-Aldana; Elva Jiménez-Hernández; Octavio Martínez-Villegas; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré; Sara A Ochoa; Juan Xicohtencatl-Cortes; Ariadnna Cruz-Córdova; Sergio Zavala-Vega; Mariana García-Jiménez; Alejandra Contreras-Ramos; José Refugio Torres-Nava; Guillermo Mora-Ramiro; José Arellano-Galindo
Journal:  Microorganisms       Date:  2020-06-26

6.  Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.

Authors:  Hui-Chen Lin; Yao Chang; Ruo-Yu Chen; Liang-Yi Hung; Paul Chih-Hsueh Chen; Ya-Ping Chen; L Jeffrey Medeiros; Po-Min Chiang; Kung-Chao Chang
Journal:  Cancer Sci       Date:  2021-02-16       Impact factor: 6.716

7.  The grim reaper evading modern medicine: aspergillosis, adenovirus, and Hodgkin lymphoma.

Authors:  Larry Nichols; Justin Armstrong; Cody Atkinson
Journal:  Autops Case Rep       Date:  2020-09-02

8.  Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein-Barr Virus in Classical Hodgkin Lymphoma.

Authors:  Antonio Santisteban-Espejo; Jose Perez-Requena; Lidia Atienza-Cuevas; Julia Moran-Sanchez; Maria Del Carmen Fernandez-Valle; Irene Bernal-Florindo; Raquel Romero-Garcia; Marcial Garcia-Rojo
Journal:  Viruses       Date:  2021-12-15       Impact factor: 5.048

9.  An Autopsy Case of an Elderly Patient with Classic Hodgkin Lymphoma Presenting with a Plethora of Clinical Symptoms and Signs.

Authors:  Hiroshi Kobayashi; Ryouya Seki; Masuo Ujita; Kana Hirayama; Satoshi Yamada; Riuko Ohashi; Yoshiro Otsuki; Takuya Watanabe; Tadashi Yoshino
Journal:  Am J Case Rep       Date:  2020-10-22

Review 10.  Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future.

Authors:  Marc Bienz; Salima Ramdani; Hans Knecht
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.